Good news! Our company's chairman Jing Yue has been awarded the honorary title of Ji'an City's March 8th Red Banner Holder!

Recently, Ji'an City Women's Federation announced 2022 Annual Ji'an City List of March 8th Red Banner Holders and March 8th Red Banner Collectives. Our company's Chairwoman Ms. Jing Yue was honorably listed, awarded 2022 Annual " Ji'an City March 8th Red Banner Holder " honorary title ！

( Company Chairwoman Ms. Jing Yue )

1: She has a far-sighted vision, sets strategies, and leads the company to go global!

"An established enterprise revitalized, firmly rooted domestically, heading towards the world" is the development outlook she proposed based on the company's situation. To achieve this goal, she proposed the development strategy of building a global antiserum base and emergency antibody bank. To promote the implementation of the strategy, allowing biopharmaceutical technological innovation to play a role in urban biosafety and to better safeguard the health of the general public with biotechnology, she actively communicated with government departments and innovatively proposed the construction of a ， "rapid drug response platform for treating major infectious diseases" concept, and proposed to rely on this platform to build a major infectious disease research institute and a standard sample bank for antigens and antibodies, forming an integrated arsenal for the prevention, treatment, and diagnosis of infectious or sudden infectious diseases. Currently, this proposal has received high attention from relevant departments, and various preparatory works are progressing orderly. 。 Ms. Jing delivered a speech at the

( 2022 Resilient City Development and Science & Technology Emergency Seminar on-site. 2: She deeply cultivates the industry, plans layouts, and promotes continuous industry development! )

To promote the comprehensive development of the biopharmaceutical industry, accelerate the restructuring of the bio-industry and the core business development of the biopharmaceutical industry chain, she focuses on expanding the Jiang production industry chain.

She has successively established the largest domestic GMP-compliant immune horse plasma and pregnant mare serum production base in Zhangye City, Gansu Province; in Chifeng City, Inner Mongolia, she will establish the country's first and largest erythropoietin preparation workshop compliant with EU GMP standards; in Shenzhen and Hainan, she has built cooperative R&D service platforms integrating production, academia, research, medical, and application involving cutting-edge pharmaceutical science and technology research and clinical trial CROs for medical devices. In recent years, under her leadership, the company has obtained multiple patents in the antiserum field, and the company's main product, tetanus antitoxin, has successively won the 50 "7th ASEAN Traditional Chinese Medicine Academic Conference Gold Award," "Jiangxi Province Excellent New Product," "Jiangxi Province First Batch of Ganchu Boutique Products" sales capability has risen to the top domestically, exported to more than 30 countries and regions overseas, and the excellent quality of the products has won unanimous praise from domestic and international users! 3: She leads the company, plans development, and has won multiple corporate honors! Under her ”， leadership, the company has successively received numerous honorary titles such as "National Advanced Collective in Competition Work," "Jiangxi Province Advanced Collective in Competition Work," "Jiangxi Province Excellent Enterprise," "Jiangxi Province High-tech Enterprise," "Jiangxi Province Enterprise Technology Center," "Provincial Private Technology Enterprise," "Top Ten Private Technology Enterprises in Ji'an City," "Jiangxi Province Specialized and New Enterprises," and "Jiangxi Province Specialized Little Giant Enterprises," becoming an industry leader! Under the leadership,

the company is moving towards being led by biopharmaceutical preparations, gradually

developing into a major global immune serum production supplier with a high international market position, and is expected ， to dominate the market and lead technology in the field of biopharmaceutical research, becoming one of the most valuable and competitive modern export-oriented biopharmaceutical enterprises globally. 4: She cares for the people, fights the epidemic, and safeguards public health! developing into a major global immune serum production supplier with a high international market position, She is a "practitioner of providing quality medicines for people worldwide," and as the company's board of directors' main leader, she always cares about the company's development, takes the company's mission as her own, and leads all employees to strive to practice it. Since the global outbreak of the COVID-19 pandemic in 2019, she has closely monitored the pandemic's development. At the early stage of the outbreak, she took initiative, actively mobilized the company's R&D team, negotiated cooperation with top domestic and international expert teams, and formed a COVID-19 virus R&D team. After the spread of the Omicron variant, the severity of the pandemic made her restless. To accelerate progress, she led the company's researchers to work overtime, through continuous experiments and technological breakthroughs, ， currently, the anti-COVID serum antibodies have completed pilot batch production in a clean workshop compliant with pharmaceutical GMP management standards, and preclinical research ！

work has begun.

It is believed that soon, this anti-COVID virus serum will shine in clinical COVID-19 infection treatment. 董事会主要领导，她始终心系公司发展，将公司使命作为自身使命，引领全员努力践行。自2019年新冠疫情全球暴发以来，她高度关注疫情发展动态，在疫情传播初期，主动出击，积极动员公司研发团队，与国内、国际一流的专家团队洽谈合作，组成了一支新冠病毒研发团队。在奥密克戎变异株传播后，疫情的严重性更是让她寝食难安，为了加快进度，她引领公司研发人员，加班加点，通过不断实验和技术攻关，目前抗新冠血清抗体在符合药品GMP管理规范的洁净车间里完成了中试批产品的生产，临床前研究工作已开启，相信不久，这款抗新冠病毒血清将会在临床新冠感染救治上大放异彩， Safeguarding the health of people worldwide!

Five: She is charitable at heart, takes responsibility, and deeply practices social responsibility!

During the fight against COVID-19, she personally donated to countries like Cuba, receiving the Shenzhen Red Cross contribution honor. In 2022, the company donated funds to the Ji'an City Red Cross and the City Charity Federation of 250,000 and 80,000 yuan to equip automated external defibrillators, support multiple impoverished college students to realize their university dreams, and provide one-on-one assistance to help poor rural areas escape poverty and become prosperous... She actively participates in various charitable causes ， leading by example, a phrase she often says is: The foundation of a business is development and profit, but the ultimate goal of a business is its contribution and dedication to society! Under her influence, , the company acts as a long-established biopharmaceutical enterprise, and has already made enthusiasm for social welfare, courage in social responsibility, and striving to be an outstanding caring enterprise an important part of its corporate culture.

( Some photos of charitable donations )

Ms. Jing Yue is called by friends a "striver", and is an outstanding representative of the majority of Jiangsheng employees, and a symbol of all Jiangsheng employees who are determined to strive and pursue excellence. ， She is a good role model that employees eagerly learn from! This time, this awarded " Ji'an City March 8th Red Banner Holder " is both an encouragement and a spur to all Jiangsheng people. All employees will Jiangsheng take Ms. Jing Yue as a role model, remember the corporate mission of making quality medicines for people worldwide, " and strive to be dedicated strivers, ” using technology to make good medicine, persistently serving disease prevention and treatment, and making the greatest contribution to social progress, development, and harmony! 企业使命，争做奋斗奉献者，用科技，做好药，坚持不懈地为防病治病服务，为社会的进步、发展、和谐做出最大的贡献！